Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). - Wikidata - awgldk - TriplyDB

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

http://www.wikidata.org/entity/Q50110246

about

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Different lasers and techniques for proliferative diabetic retinopathy Cardiovascular risk Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis Spectral-domain optical coherence tomography for macular edema Diabetic nephropathy - Epidemiology in Asia and the current state of treatment Relationship between HgbA1c and myocardial blood flow reserve in patients with type 2 diabetes mellitus: noninvasive assessment using real-time myocardial perfusion echocardiography.Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands.A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study.Aerobic exercise in obese diabetic patients with chronic kidney disease: a randomized and controlled pilot study.Resistance exercise training lowers HbA1c more than aerobic training in adults with type 2 diabetes Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.Protocol and baseline data from The Inala Chronic Disease Management Service evaluation study: a health services intervention study for diabetes care Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Insufficient control of morning home blood pressure in Japanese patients with hypertension associated with diabetes mellitus Effect of macular photocoagulation on visual acuity of Omani patients with clinically significant macular edema.Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.Exercise prescription in the treatment of type 2 diabetes mellitus : current practices, existing guidelines and future directions.Hypertriglyceridemic waist may explain ethnic differences in hypertension among patients with type 2 diabetes in Sweden.Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial.Near-Normalization of Glucose and Microvascular Diabetes Complications: Data from ACCORD and ADVANCE.Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study.Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population Quality improvement in practice: improving diabetes care and patient outcomes in Aboriginal Community Controlled Health Services.Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.The impact of a diabetes local enhanced service on quality outcome framework diabetes outcomes.Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes.Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.Preoperative medical treatment in patients undergoing diabetic foot surgery with a Wagner Grade-3 or higher ulcer: a retrospective analysis of 52 patients.Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians

P2860

Q24186667-EB4703C7-A430-4B4A-82CE-2583BD00B794 Q24202505-EE4E2792-19D3-4A2F-9DC3-2CA172116162 Q24236456-DBE1F4EB-4F28-46DC-A36A-7BC05BAC66B2 Q26470625-CB184494-C908-432E-B7E3-463FC1B0E115 Q26825634-217E1D12-5105-48A9-AC6B-83878832EF0F Q26860467-B0A81F9C-8936-4324-9382-82319F5C974C Q27016124-46C5780B-6A10-49DE-87DB-C9C53D2FBFCC Q28742785-7B12A7A8-3523-43EF-B810-1AC9B5F16FFB Q30433420-E80074AD-C521-4155-8C8B-6EEFCBBDDCAE Q30499098-233F7F7D-07AC-48C1-8F3D-F23EA3B94119 Q33355710-15944022-C075-4E65-9CC1-12D313C4D797 Q33359510-821FC976-5BA1-480D-A8DD-C3F071B9F7D3 Q33490033-6587A341-0C1E-4C88-88B2-BFBA27B6C849 Q33552655-AD2B82FC-A6B4-48B1-A40B-F5A72FC0790E Q33567762-8E545E1D-0FBD-4B57-B406-FB9E5C7168DC Q33573537-2EE1757C-B58D-4B93-8ED6-66B9596AAA91 Q33584386-0DD4FC84-DBB0-42B6-A1CE-4E8FD6ABEEB8 Q33584703-0DC83C33-2DC5-46E1-AE18-AAFF71F537BF Q33585498-5B6EA630-96E6-4A2B-B6C6-D5C94D60C603 Q33645419-F6BFB1EA-5CFF-4628-B945-F6FF96E54FD3 Q33705724-14A28CB7-6908-4AFF-A8CC-9C055EDB611B Q34133889-D9BBE131-7CA8-4200-AD44-B81A7AF0F25A Q34179368-E0849059-A7E4-42F7-8373-58ADAEAC2D21 Q34322365-0430A34F-C7EC-4EB0-BA20-AA67AEBD39F3 Q34399833-084D5207-12C4-4850-A1D9-7F5E1002A7CA Q34422037-63795402-6275-47EA-814A-9E3AD2BDB810 Q34475442-FBCFC92A-636C-4B8F-AEE6-9EA3DFC2D567 Q34536946-F2CACBD6-1F4A-43CC-9343-D51F2BC034BA Q34798255-CB58849E-80A7-4AE7-8398-E89CB5019E27 Q34804022-BABFF7E3-7289-4F15-A685-B6600E9E9CE1 Q34994502-2171F99E-23E4-4A7E-A75F-53104B027D0F Q35003229-EB80C0DC-8929-4B27-B78C-BF8F1BA357A8 Q35073167-E5023770-2CAC-46F2-9AD8-F2F46A6DA141 Q35148838-B2515CDA-01C6-4DAD-9D27-A28F281F183B Q35193812-17E5092B-A714-41C8-9FE9-F4F0BE7845E5 Q35976468-16A2FF6C-119D-4B1E-8A7E-6670889B0649 Q36074329-2125939B-034B-4E6D-BF58-E70ACD5FA83D Q36183879-1B4B0E4F-6100-4FDE-81FB-D99FE86C0F13 Q36270259-E01F717C-9A1D-4856-8C41-C17DA41CC15D Q36443768-C8ED81D8-34F3-42F1-8240-CB7CB94129B1

P2860

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

http://www.wikidata.org/entity/Q50110246

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Additive effects of glycaemia ...... bservational study (UKPDS 75).

@en

Additive effects of glycaemia ...... rospective observational study

@nl

type

label

Additive effects of glycaemia ...... bservational study (UKPDS 75).

@en

Additive effects of glycaemia ...... rospective observational study

@nl

prefLabel

Additive effects of glycaemia ...... bservational study (UKPDS 75).

@en

Additive effects of glycaemia ...... rospective observational study

@nl

P1433

Q50110246-9EC39683-F3BD-47B1-BF07-B58934ACA774

P1476

Q50110246-C59199E6-50DE-4C80-9DA1-0FACEF4EF9AB

P2093

Q50110246-5DA448C5-F17B-4919-A474-FEF8BBE5527B

Q50110246-83843055-FE1A-4432-8520-432CD1334287

Q50110246-B6940A1E-A405-470D-B35D-FBD5D42E585E

Q50110246-C296EA53-D19C-41D7-B849-38DD24988968

P2860

Q50110246-249895C0-93B3-45CA-95C0-B714A1851687

Q50110246-44C683FC-29AB-4A88-BD2B-2649A68DBEE6

Q50110246-7F49D7B3-324E-4E72-A33B-CAF629974E7B

Q50110246-B0F7FADA-99C7-46D8-8A42-9B162B5E5AC4

Q50110246-CB5D616D-FD7E-42A8-B928-92CEEE744A24

P2888

Q50110246-13C25CE9-33BD-4EDA-AFF7-F712197104B8

P304

Q50110246-7B8A7919-9949-43C6-B2FD-828966CEA04E

P31

Q50110246-1616494F-C28A-405C-BB09-CDC36DE6BF7D

P356

Q50110246-7DB221BC-2630-46FB-ADD9-F03B518D0DE9

P433

Q50110246-DFD7F4C2-2903-4873-959E-C2CD9EDDE9DB

P478

Q50110246-E382F8F2-6E2C-4CF5-A1C9-9AE9DACAD839

P50

Q50110246-0C57CC08-6A40-4C42-8AAC-0B484355FDB2

Q50110246-2423E76F-3CF9-4DEB-8FF0-378C95804043

P577

Q50110246-B27B8485-23C2-4B85-9493-E7211B87FA07

P5875

Q50110246-A327A3A4-CA9D-4CE2-88E2-5D088205F188

P698

Q50110246-F3434B2C-481E-4DC1-ABAE-B6FED9ED91FB

P921

Q50110246-69FC952D-02CF-4A00-9434-AEF19A46EF7A

P356

S00125-006-0297-1

P1433

P1476

Additive effects of glycaemia ...... observational study (UKPDS 75)

@en

P2093

A I Adler

http://www.w3.org/2001/XMLSchema#string

C A Cull

http://www.w3.org/2001/XMLSchema#string

D R Matthews

http://www.w3.org/2001/XMLSchema#string

H A W Neil

http://www.w3.org/2001/XMLSchema#string

P2860

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

British Hypertension Society guidelines for hypertension management 1999: summary

Glycemic control of older adults with type 2 diabetes: findings from the Third National Health and Nutrition Examination Survey, 1988-1994.

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

P2888

s00125-006-0297-1

P304

1761-1769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-006-0297-1

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7047000

http://www.w3.org/2001/XMLSchema#string

P698

16736131

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes